{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:33:23Z","timestamp":1791200003727,"version":"4.2.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-026-03769-y","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T07:34:42Z","timestamp":1772177682000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The challenges and opportunities for equitable global access to medications for paediatric rheumatology in low-to middle-income countries: a review on behalf of the Paediatric Global Task Force for Musculoskeletal Health"],"prefix":"10.1186","volume":"28","author":[{"given":"Christiaan","family":"Scott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waheba","family":"Slamang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Dushnicky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Hause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayodele","family":"Faleye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Furia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Octavio Aragon","family":"Cuevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djohra","family":"Hadef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Munro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisse","family":"Nzabonimpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Migowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Paediatric Global Task Force for Musculoskeletal Health","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cylie","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soamarat","family":"Vilayiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafa","family":"Hamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipa","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Wyllie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Saad","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulaiman","family":"AL-Mayouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara L\u00edvia","family":"Serafim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Megeean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Herrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumaira","family":"Farman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh","family":"Pandiarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah Kopanski","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Shearer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Perfetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Peixoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"issue":"6","key":"3769_CR1","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/annrheumdis-2018-213030","volume":"77","author":"A Ravelli","year":"2018","unstructured":"Ravelli A, Consolaro A, Horneff G, Laxer RM, Lovell DJ, Wulffraat NM, et al. Treating juvenile idiopathic arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2018;77(6):819\u201328.","journal-title":"Ann Rheum Dis"},{"issue":"17","key":"3769_CR2","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s40265-018-1009-0","volume":"78","author":"BK Chen","year":"2018","unstructured":"Chen BK, Yang YT, Bennett CL. Why biologics and biosimilars remain so expensive: despite two wins for biosimilars, the Supreme Court\u2019s recent rulings do not solve fundamental barriers to competition. Drugs. 2018;78(17):1777\u201381.","journal-title":"Drugs"},{"issue":"4","key":"3769_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S2352-4642(19)30027-6","volume":"3","author":"A Consolaro","year":"2019","unstructured":"Consolaro A, Giancane G, Alongi A, van Dijkhuizen EHP, Aggarwal A, Al-Mayouf SM, et al. Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study. Lancet Child Adolesc Health. 2019;3(4):255\u201363.","journal-title":"Lancet Child Adolesc Health"},{"issue":"1","key":"3769_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12969-020-00443-8","volume":"18","author":"M Dave","year":"2020","unstructured":"Dave M, Rankin J, Pearce M, Foster HE. Global prevalence estimates of three chronic musculoskeletal conditions: club foot, juvenile idiopathic arthritis and juvenile systemic lupus erythematosus. Pediatr Rheumatol. 2020;18(1):49.","journal-title":"Pediatr Rheumatol"},{"issue":"1","key":"3769_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.rdc.2021.09.001","volume":"48","author":"C Scott","year":"2022","unstructured":"Scott C, Sawhney S, Lewandowski LB. Pediatric rheumatic disease in lower to middle-income countries: impact of global disparities, ancestral diversity, and the path forward. Rheum Dis Clin North Am. 2022;48(1):199\u2013215.","journal-title":"Rheum Dis Clin North Am"},{"issue":"5","key":"3769_CR6","doi-asserted-by":"publisher","first-page":"101566","DOI":"10.1016\/j.berh.2020.101566","volume":"34","author":"HE Foster","year":"2020","unstructured":"Foster HE, Scott C, Tiderius CJ, Dobbs MB, Ang E, Charuvanij S, et al. Improving musculoskeletal health for children and young people\u2013a \u2018call to action.\u2019 Best Pract Res Clin Rheumatol. 2020;34(5):101566.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"3769_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41584-020-0368-6","volume":"16","author":"HE Foster","year":"2020","unstructured":"Foster HE, Scott C. Update the WHO EML to improve global paediatric rheumatology. Nat Rev Rheumatol. 2020;16(3):123.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"3769_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12969-021-00498-1","volume":"19","author":"S Tangcheewinsirikul","year":"2021","unstructured":"Tangcheewinsirikul S, Tang SP, Smith N, Sukharomana M, Charuvanij S, Vilaiyuk S, et al. Delivery of paediatric rheumatology care: a survey of current clinical practice in Southeast Asia and Asia-Pacific regions. Pediatr Rheumatol. 2021;19(1):11.","journal-title":"Pediatr Rheumatol"},{"issue":"4","key":"3769_CR9","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1377\/hlthaff.26.4.972","volume":"26","author":"K Xu","year":"2007","unstructured":"Xu K, Evans DB, Carrin G, Aguilar-Rivera AM, Musgrove P, Evans T. Protecting households from catastrophic health spending. Health affairs (Project Hope). 2007;26(4):972\u201383.","journal-title":"Health affairs (Project Hope)"},{"issue":"1","key":"3769_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12969-022-00752-0","volume":"20","author":"W Slamang","year":"2022","unstructured":"Slamang W, Smith N, Scott C, Foster H. Revising the WHO essential medicines list for paediatric rheumatology update. Pediatr Rheumatol Online J. 2022;20(1):89.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"3769_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12969-024-00997-x","volume":"22","author":"W Slamang","year":"2024","unstructured":"Slamang W, Scott C, Foster HE. A quantitative comparison between the essential medicines for rheumatic diseases in children and young people in Africa and the WHO model list. Pediatr Rheumatol. 2024;22(1):63.","journal-title":"Pediatr Rheumatol"},{"issue":"1","key":"3769_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12969-024-01000-3","volume":"22","author":"AN Migowa","year":"2024","unstructured":"Migowa AN, Hamdi W, Hashad S, Etayari H, Abushhaiwia A, Ferjani H, et al. Development of the paediatric society of the African league against rheumatism (PAFLAR) JIA registry and clinical profile of JIA in Africa from the PAFLAR JIA registry. Pediatr Rheumatol. 2024;22(1):67.","journal-title":"Pediatr Rheumatol"},{"issue":"1","key":"3769_CR13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12969-021-00608-z","volume":"19","author":"R Kraus","year":"2021","unstructured":"Kraus R, Yeung RSM, Persaud N. Biologic medicine inclusion in 138 national essential medicines lists. Pediatr Rheumatol Online J. 2021;19(1):140.","journal-title":"Pediatr Rheumatol Online J"},{"key":"3769_CR14","unstructured":"Rare Diseases Act of 2002, United States Congress, 107th Congress Sess. (2002)."},{"issue":"6","key":"3769_CR15","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1586\/ecp.09.40","volume":"2","author":"SE Kern","year":"2009","unstructured":"Kern SE. Challenges in conducting clinical trials in children: approaches for improving performance. Expert Rev Clin Pharmacol. 2009;2(6):609\u201317.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"9","key":"3769_CR16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nrrheum.2013.105","volume":"9","author":"DJ Lovell","year":"2013","unstructured":"Lovell DJ, Ruperto N, Giannini EH, Martini A. Advances from clinical trials in juvenile idiopathic arthritis. Nat Rev Rheumatol. 2013;9(9):557\u201363.","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"3769_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s40272-017-0244-2","volume":"19","author":"SJ Balevic","year":"2017","unstructured":"Balevic SJ, Becker ML, Cohen-Wolkowiez M, Schanberg LE. Clinical trial design in juvenile idiopathic arthritis. Paediatr Drugs. 2017;19(5):379\u201389.","journal-title":"Paediatr Drugs"},{"issue":"5","key":"3769_CR18","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s10067-014-2841-6","volume":"34","author":"M Al Maini","year":"2015","unstructured":"Al Maini M, Adelowo F, Al Saleh J, Al Weshahi Y, Burmester GR, Cutolo M, et al. The global challenges and opportunities in the practice of rheumatology: white paper by the World Forum on Rheumatic and Musculoskeletal Diseases. Clin Rheumatol. 2015;34(5):819\u201329.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"3769_CR19","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/acr.24497","volume":"74","author":"CK Correll","year":"2022","unstructured":"Correll CK, Ditmyer MM, Mehta J, Imundo LF, Klein-Gitelman MS, Monrad SU, et al. 2015 American college of rheumatology workforce study and demand projections of pediatric rheumatology workforce, 2015-2030. Arthritis Care Res (Hoboken). 2022;74(3):340\u20138.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"3769_CR20","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/BOR.0000000000000726","volume":"32","author":"LB Lewandowski","year":"2020","unstructured":"Lewandowski LB. Tackling global challenges in pediatric rheumatology. Curr Opin Rheumatol. 2020;32(5):414\u201320.","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"3769_CR21","doi-asserted-by":"publisher","first-page":"101983","DOI":"10.1016\/j.berh.2024.101983","volume":"38","author":"S Vilaiyuk","year":"2024","unstructured":"Vilaiyuk S, Hadef D, Hamdi W, Scott C, Slamang W, Foster HE, et al. The inequity of global healthcare in pediatric rheumatology. Best Pract Res Clin Rheumatol. 2024;38(3):101983.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"7","key":"3769_CR22","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s00467-020-04517-3","volume":"35","author":"MFG Goulart","year":"2020","unstructured":"Goulart MFG, Alves AGF, Farhat J, Braga ALF, Pereira LAA, de Faria Coimbra Lichtenfels AJ, et al. Influence of air pollution on renal activity in patients with childhood-onset systemic lupus erythematosus. Pediatr Nephrol. 2020;35(7):1247\u201355.","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"3769_CR23","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cct.2013.05.009","volume":"36","author":"SC Nair","year":"2013","unstructured":"Nair SC, Ibrahim H, Celentano DD. Clinical trials in the Middle East and North Africa (MENA) region: grandstanding or grandeur? Contemp Clin Trials. 2013;36(2):704\u201310.","journal-title":"Contemp Clin Trials"},{"issue":"3","key":"3769_CR24","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/acr.24474","volume":"74","author":"JN Williams","year":"2022","unstructured":"Williams JN, Dall\u2019Era M, Lim SS, Feldman CH, Arntsen KA, Blazer AD, et al. Increasing ancestral diversity in systemic lupus erythematosus clinical studies. Arthritis Care Res (Hoboken). 2022;74(3):420\u20136.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"3769_CR25","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1177\/0961203318791046","volume":"27","author":"A Aggarwal","year":"2018","unstructured":"Aggarwal A, Phatak S, Srivastava P, Lawrence A, Agarwal V, Misra R. Outcomes in juvenile onset lupus: single center cohort from a developing country. Lupus. 2018;27(11):1867\u201375.","journal-title":"Lupus"},{"issue":"4","key":"3769_CR26","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ana.23672","volume":"72","author":"SM Murphy","year":"2012","unstructured":"Murphy SM, Puwanant A, Griggs RC. Consortium for clinical investigations of neurological C, Inherited neuropathies consortium consortia of the rare disease clinical research N. Unintended effects of orphan product designation for rare neurological diseases. Ann Neurol. 2012;72(4):481\u201390.","journal-title":"Ann Neurol"},{"key":"3769_CR27","unstructured":"APLAR 26th Asia-Pacific League of Associations for Rheumatology Congress, 21\u201325 August 2024. Int J Rheum Dis. 2024;27 Suppl 3:e15345."},{"issue":"1","key":"3769_CR28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12969-020-00451-8","volume":"18","author":"HE Foster","year":"2020","unstructured":"Foster HE, Scott C, Tiderius CJ, Dobbs MB. The paediatric global musculoskeletal task force - \u201ctowards better MSK health for all.\u201d Pediatr Rheumatol Online J. 2020;18(1):60.","journal-title":"Pediatr Rheumatol Online J"},{"key":"3769_CR29","unstructured":"Society PRE. PReS Working Parties. 2025. Available from: https:\/\/www.pres.eu\/working-parties\/msk-working-party.html."},{"key":"3769_CR30","unstructured":"Global TS. Tin Soldiers Global 2025. Available from: https:\/\/www.tinsoldiers.org."},{"key":"3769_CR31","doi-asserted-by":"crossref","unstructured":"Smith N, Jandial S, Wyllie R, English C, Davies B, Khubchandani R, et al. 260 Globalisation of Paediatric Musculoskeletal Matters (PMM). Rheumatology. 2018;57(suppl_3):key075. 484.","DOI":"10.1093\/rheumatology\/key075.484"},{"key":"3769_CR32","unstructured":"https:\/\/www.pmmonline.org\/doctor\/clinical-assessment\/examination\/. Paediatric Musculoskeletal Matters Online. 2024."},{"issue":"1","key":"3769_CR33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12969-024-00978-0","volume":"22","author":"J McColl","year":"2024","unstructured":"McColl J, Mwizerwa O, Scott C, Tse SM, Foster HE. Pediatric rheumatology education: the virtual frontier a review. Pediatr Rheumatol. 2024;22(1):60.","journal-title":"Pediatr Rheumatol"},{"issue":"6","key":"3769_CR34","doi-asserted-by":"publisher","first-page":"e006045","DOI":"10.1136\/bmjgh-2021-006045","volume":"6","author":"AM Briggs","year":"2021","unstructured":"Briggs AM, Huckel Schneider C, Slater H, Jordan JE, Parambath S, Young JJ, et al. Health systems strengthening to arrest the global disability burden: empirical development of prioritised components for a global strategy for improving musculoskeletal health. BMJ Glob Health. 2021;6(6):e006045.","journal-title":"BMJ Glob Health"},{"key":"3769_CR35","unstructured":"International. RD. World Health Assembly Resolution on Rare Diseases2025. Available from: https:\/\/www.rarediseasesinternational.org\/wha-resolution\/."},{"key":"3769_CR36","unstructured":"UNGA. Zero draft on the prevention and control of noncommunicable diseases and the promotion of mental health and well-being2025 30 June 2025. Available from: https:\/\/www.un.org\/pga\/wp-content\/uploads\/sites\/109\/2025\/05\/Zero-Draft-PD-on-NCDs-and-Mental-Health-13-May_.pdf."},{"issue":"1","key":"3769_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12969-021-00496-3","volume":"19","author":"C Scott","year":"2021","unstructured":"Scott C, Smith N, James R, Whitehead B, Green R, Foster HE. Revising the WHO essential medicines list for paediatric rheumatology. Pediatr Rheumatol. 2021;19(1):10.","journal-title":"Pediatr Rheumatol"},{"key":"3769_CR38","unstructured":"Organization WH. WHO guideline on country pharmaceutical pricing policies. 2020. p. 70."},{"key":"3769_CR39","unstructured":"World Health Organisation Essential Medicines List. 2023. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/371090\/WHO-MHP-HPS-EML-2023.02-eng.pdf?sequence=1."},{"issue":"1","key":"3769_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2989\/16085906.2017.1296874","volume":"16","author":"SC Sabi","year":"2017","unstructured":"Sabi SC, Rieker M. The role of civil society in health policy making in South Africa: a review of the strategies adopted by the Treatment Action Campaign. Afr J AIDS Res. 2017;16(1):57\u201364.","journal-title":"Afr J AIDS Res"},{"issue":"6","key":"3769_CR41","doi-asserted-by":"publisher","first-page":"e011881","DOI":"10.1136\/bmjgh-2023-011881","volume":"8","author":"L Privor-Dumm","year":"2023","unstructured":"Privor-Dumm L, Excler JL, Gilbert S, Abdool Karim SS, Hotez PJ, Thompson D, et al. Vaccine access, equity and justice: COVID-19 vaccines and vaccination. BMJ Glob Health. 2023;8(6):e011881.","journal-title":"BMJ Glob Health"},{"issue":"5","key":"3769_CR42","first-page":"774","volume":"28","author":"C Scott","year":"2010","unstructured":"Scott C, Meiorin S, Filocamo G, Lanni S, Valle M, Martinoli C, et al. A reappraisal of intra-articular corticosteroid therapy in juvenile idiopathic arthritis. Clin Exp Rheumatol. 2010;28(5):774\u201381.","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"3769_CR43","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1093\/rheumatology\/keg358","volume":"42","author":"F Zulian","year":"2003","unstructured":"Zulian F, Martini G, Gobber D, Agosto C, Gigante C, Zacchello F. Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis. Rheumatology (Oxford). 2003;42(10):1254\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"3769_CR44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12969-022-00666-x","volume":"20","author":"S Rubin","year":"2022","unstructured":"Rubin S, Ohana O, Goldberg O, Peled O, Gendler Y, Habot-Wilner Z, et al. The efficacy and safety of intra-articular injection of triamcinolone acetonide versus triamcinolone hexacetonide for treatment of juvenile idiopathic arthritis. Pediatr Rheumatol. 2022;20(1):5.","journal-title":"Pediatr Rheumatol"},{"key":"3769_CR45","unstructured":"UK Parliament, Triamcinolone Hexacetonide, Question for Department of Health and Social Care UIN 10803, tabled on 22 January 2024, answered on 25 January 2024. Available from: https:\/\/questions-statements.parliament.uk\/written-questions\/detail\/2024-01-22\/10803."},{"issue":"1","key":"3769_CR46","doi-asserted-by":"publisher","first-page":"e145","DOI":"10.1016\/S2214-109X(22)00460-0","volume":"11","author":"S Morin","year":"2023","unstructured":"Morin S, Segafredo G, Piccolis M, Das A, Das M, Loffredi N, et al. Expanding access to biotherapeutics in low-income and middle-income countries through public health non-exclusive voluntary intellectual property licensing: considerations, requirements, and opportunities. Lancet Glob Health. 2023;11(1):e145\u201354.","journal-title":"Lancet Glob Health"},{"key":"3769_CR47","unstructured":"WHO WHOHPPaSIN-PN. 2022. Available from: https:\/\/www.who.int\/teams\/health-product-and-policy-standards\/inn."},{"key":"3769_CR48","unstructured":"Agency MaHpR. 2022. Available from: https:\/\/www.gov.uk\/government\/organisations\/medicines-and-healthcare-products-regulatory-agency."},{"key":"3769_CR49","doi-asserted-by":"publisher","first-page":"102671","DOI":"10.1016\/j.jhealeco.2022.102671","volume":"85","author":"LX Wang","year":"2022","unstructured":"Wang LX. Global drug diffusion and innovation with the medicines patent pool. J Health Econ. 2022;85:102671.","journal-title":"J Health Econ"},{"key":"3769_CR50","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fphar.2016.00193","volume":"7","author":"E Moorkens","year":"2016","unstructured":"Moorkens E, Jonker-Exler C, Huys I, Declerck P, Simoens S, Vulto AG. Overcoming barriers to the market access of biosimilars in the European Union: the case of biosimilar monoclonal antibodies. Front Pharmacol. 2016;7:193.","journal-title":"Front Pharmacol"},{"issue":"2","key":"3769_CR51","doi-asserted-by":"publisher","first-page":"lsac022","DOI":"10.1093\/jlb\/lsac022","volume":"9","author":"R Goode","year":"2022","unstructured":"Goode R, Chao B. Biological patent thickets and delayed access to biosimilars, an American problem. J Law Biosci. 2022;9(2):lsac022.","journal-title":"J Law Biosci"},{"issue":"14","key":"3769_CR52","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.2174\/1871520622666220302114313","volume":"22","author":"B Pelicario Vargas","year":"2022","unstructured":"Pelicario Vargas B, Sari MHM, Ferreira LM. Trastuzumab in breast cancer treatment: the era of biosimilars. Anticancer Agents Med Chem. 2022;22(14):2507\u201316.","journal-title":"Anticancer Agents Med Chem"},{"key":"3769_CR53","doi-asserted-by":"publisher","first-page":"1443529","DOI":"10.3389\/fped.2025.1443529","volume":"13","author":"H Silim","year":"2025","unstructured":"Silim H, Wamithi S, Riang\u2019a RM, Migowa A. Experiences among parents caring for children with juvenile idiopathic arthritis at a tertiary referral hospital in Kenya. Front Pediatr. 2025;13:1443529.","journal-title":"Front Pediatr"},{"key":"3769_CR54","unstructured":"Universal PAHOMFf, Americas. AtHaUHCit. 2022. Available from: https:\/\/www.paho.org\/en."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-026-03769-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03769-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03769-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T01:02:06Z","timestamp":1775264526000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13075-026-03769-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3769"],"URL":"https:\/\/doi.org\/10.1186\/s13075-026-03769-y","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"12 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}